Naringenin Prevents Osteoblast Senescence In D-Galactose-Induced Aging Conditions Via Estrogen Receptor-Mediated Pathway
As we age, our bones can become weaker, a condition known as senile osteoporosis. This often involves the aging and reduced function of osteoblasts, the cells responsible for building new bone. Recent research has shed light on a promising natural compound that could help combat this process.
This study investigated a plant-derived compound called naringenin, which is known for its various beneficial properties, including fighting inflammation and promoting cell growth. The researchers explored its potential to protect bones in an aging model.
They found that naringenin significantly improved the internal structure of bones and encouraged the process of mineralization, which is essential for bone hardening. It also positively influenced markers related to bone health. Delving deeper, the scientists observed that naringenin helped bone-forming cells mature properly and reduced signs of cellular aging, programmed cell death, and the production of harmful molecules called reactive oxygen species. Crucially, this protective effect was found to be mediated through a pathway involving estrogen receptors, which are vital for maintaining bone density. These findings suggest that naringenin could be a valuable natural agent in the fight against age-related bone weakening.
Source: link to paper